Corbus Pharmaceuticals Holdings (CRBP) Invested Capital (2013 - 2025)

Corbus Pharmaceuticals Holdings' Invested Capital history runs 13 years deep, the most recent figure standing at $147.5 million for Q4 2025.

• In Q4 2025, Invested Capital rose 3.56% year-over-year to $147.5 million; the TTM figure through Dec 2025 stood at $147.5 million (up 3.56% YoY), while the FY2025 annual figure was $147.5 million, up 3.56% from the prior year.
• Invested Capital was $147.5 million for Q4 2025 at Corbus Pharmaceuticals Holdings, up from $92.1 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $150.5 million in Q3 2024 to a low of $9.0 million in Q4 2023.
• Historically, Invested Capital has averaged $84.6 million across 5 years, with a median of $83.9 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Invested Capital plunged 82.61% in 2023, then jumped 1482.01% in 2024.
• A 5-year view of Invested Capital shows it stood at $87.8 million in 2021, then sank by 41.06% to $51.8 million in 2022, then slumped by 82.61% to $9.0 million in 2023, then surged by 1482.01% to $142.4 million in 2024, then grew by 3.56% to $147.5 million in 2025.
• The last three Invested Capital figures came in at $147.5 million (Q4 2025), $92.1 million (Q3 2025), and $111.0 million (Q2 2025), per Business Quant data.